Join Mailing List   |   Jobs   |   Print Page   |   Contact Us   |   Sign In   |   Join
How I Treat TTP
Tell a Friend About This EventTell a Friend
How I Treat TTP

 Export to Your Calendar 7/21/2020
When: Tuesday, July 21, 2020
14:00 UTC

« Go to Upcoming Event List  

How I Treat TTP


July 21, 2020 14:00 - 15:00 UTC


Ilaria Mancini "Diagnosis"

Paul Knoebl "Treatment"

Moderator: Spero Cataland





Ilaria Mancini

Biography coming soon

Prof. Paul Knoebl, MD

Paul Knoebl is Senior Physician at the Division of Haematology and Haemostatis at the Medical University of Vienna in Vienna, Austria. He has a training in internal medicine and has specialized on hematology/oncology and intensive care medicine.

Prof. Knoebl has many years of clinical experience in treating all kinds of blood disorders, including stem cell transplantation, and he is also an experienced intensive care physician.

His scientific interests are focused on clinical and basic research on blood coagulation, fibrinolysis, endothelial cell function, haemophilia, diabetes mellitus, haematologic malignancies, intensive care medicine, thrombotic microangiopathy and coagulation lab techniques. He has authored and co-authored over 200 scientific articles and book chapter publications, and serves as a reviewer and section editor for several important medical journals. 

Prof. Knoebl has conducted a variety of clinical trials as principal investigator or co-investigator and has served as a member of steering committees or data safety monitoring boards for several projects.

He is a member of several organization such as: International Society on Thrombosis and Hemostasis; Society on Thrombosis and Hemostasis Research (GTH); Austrian Society of Internal Medicine; Austrian Society of Hematology and Oncology. 

Spero Cataland

Dr. Spero Cataland is a Professor of Internal Medicine in the Division of Hematology at the Wexner Medical Center at The Ohio State University. He is also the Director of the Benign Hematology Program at Ohio State University. Dr. Cataland received his medical degree from Ohio State University College of Medicine and completed his residency at Ohio State University Hospital, after which he went on to complete fellowship training in hematology/oncology at the University of Chicago Medical Center. After completing his training in hematology he returned to Ohio State University where he presently remains on the faculty.

Dr. Cataland's clinical and research interests include thrombotic thrombocytopenic purpura (TTP) and atypical hemolytic uremic syndrome (aHUS) with an emphasis on immune-mediated TTP (iTTP).  Dr. Cataland directs the Biomarker Reference Laboratory at Ohio State University that performs correlative laboratory studies for ongoing research.  Dr. Cataland has a long standing interest in novel therapeutic approaches to iTTP as well as ongoing research emphasis to better understand the development of long-term complications in patients with a prior history of TTP and the mechanisms for their development.  Dr. Cataland has also worked to establish the United States Thrombotic Microangiopathy Clinical Consortium, an organization of over 15 academic medical centers across the United States that was organized for the purposes of conducting collaborative research in TTP and aHUS.

Membership Management Software Powered by YourMembership  ::  Legal
This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.